Research Reports

Key takeaways

Board appointed Nicholas Johnson, 38, as Class III director effective May 8, 2026, term until 2029 annual meeting.

Appointment by Churchill Sponsor X LLC under Section 8.09 of Merger Agreement dated February 17, 2026.

Mr. Johnson serves as Partner at Archimedes Advisor Group and Managing Director at M. Klein & Company, affiliate providing advisory services.

Determined not independent due to affiliation with Advisor under $250,000 quarterly fee agreement; no committee assignments.

No director compensation under Non-Employee Director Policy while Advisory Agreement in effect; entered standard indemnification agreement.

No family relationships or other reportable related party transactions with Mr. Johnson.

Full analysis

The appointment of Nicholas Johnson to Infleqtion's Board as a Class III director strengthens ties to the Churchill Capital franchise, reflecting ongoing post-merger governance arrangements from the February 2026 Merger Agreement. His extensive background in investment banking at Morgan Stanley and current leadership at Archimedes Advisor Group and M. Klein & Company positions him to advise on strategic and capital markets matters. However, his non-independent status due to the Advisory Agreement—providing quarterly fees of $250,000 plus transaction-based compensation—limits him from Board committees, signaling potential conflicts managed through disclosure. This change aligns with sponsor rights and maintains continuity without additional director pay during the two-year advisory term.

INFQ · Churchill Capital Corp X

Summary

Key takeaways

Full analysis